These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New macrolides or new quinolones as monotherapy for patients with community-acquired pneumonia: our cup runneth over? Yu VL; Vergis EN Chest; 1998 May; 113(5):1158-9. PubMed ID: 9596286 [No Abstract] [Full Text] [Related]
4. [Treatment for Legionnaires' disease. Macrolides or quinolones?]. Falcó V; Molina I; Juste C; Crespo M; Almirante B; Pigrau C; Ferrer A; Bravo C; Palomar M; Pahissa A Enferm Infecc Microbiol Clin; 2006; 24(6):360-4. PubMed ID: 16792936 [TBL] [Abstract][Full Text] [Related]
5. The treatment of Legionnaires' disease. Dedicoat M; Venkatesan P J Antimicrob Chemother; 1999 Jun; 43(6):747-52. PubMed ID: 10404312 [No Abstract] [Full Text] [Related]
6. β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. Garin N; Genné D; Carballo S; Chuard C; Eich G; Hugli O; Lamy O; Nendaz M; Petignat PA; Perneger T; Rutschmann O; Seravalli L; Harbarth S; Perrier A JAMA Intern Med; 2014 Dec; 174(12):1894-901. PubMed ID: 25286173 [TBL] [Abstract][Full Text] [Related]
7. Treatment of legionnaires' disease. Klein NC; Cunha BA Semin Respir Infect; 1998 Jun; 13(2):140-6. PubMed ID: 9643392 [TBL] [Abstract][Full Text] [Related]
10. Legionella pneumonia in the Niagara Region, Ontario, Canada: a case series. Cargnelli S; Powis J; Tsang JL J Med Case Rep; 2016 Dec; 10(1):336. PubMed ID: 27906087 [TBL] [Abstract][Full Text] [Related]
11. Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study. Griffin AT; Peyrani P; Wiemken T; Arnold F Int J Tuberc Lung Dis; 2010 Apr; 14(4):495-9. PubMed ID: 20202309 [TBL] [Abstract][Full Text] [Related]
16. Treatment and outcome of 104 hospitalized patients with legionnaires' disease. Howden BP; Stuart RL; Tallis G; Bailey M; Johnson PD Intern Med J; 2003 Nov; 33(11):484-8. PubMed ID: 14656249 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Efficacy of Antimicrobial Agents Among Hospitalized Patients With Mycoplasma pneumoniae Pneumonia in Japan During Large Epidemics of Macrolide-Resistant M. pneumoniae Infections: A Nationwide Observational Study. Tashiro M; Fushimi K; Kawano K; Takazono T; Saijo T; Yamamoto K; Kurihara S; Imamura Y; Miyazaki T; Yanagihara K; Mukae H; Izumikawa K Clin Infect Dis; 2017 Nov; 65(11):1837-1842. PubMed ID: 29020161 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides. Blázquez Garrido RM; Espinosa Parra FJ; Alemany Francés L; Ramos Guevara RM; Sánchez-Nieto JM; Segovia Hernández M; Serrano Martínez JA; Huerta FH Clin Infect Dis; 2005 Mar; 40(6):800-6. PubMed ID: 15736011 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial strategy for severe community-acquired legionnaires' disease: a multicentre retrospective observational study. Cecchini J; Tuffet S; Sonneville R; Fartoukh M; Mayaux J; Roux D; Kouatchet A; Boissier F; Tchir M; Thyrault M; Maury E; Jochmans S; Mekontso Dessap A; Brun-Buisson C; de Prost N J Antimicrob Chemother; 2017 May; 72(5):1502-1509. PubMed ID: 28204479 [TBL] [Abstract][Full Text] [Related]
20. Community-acquired Legionnaires' disease at a medical center in northern Taiwan. Kao WF; Wang JT; Sheng WH; Chen YC J Microbiol Immunol Infect; 2019 Jun; 52(3):465-470. PubMed ID: 28964650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]